Serge Saxonov, PhD, 10x Genomics co-founder and CEO 10x’s co ... that is designed to lower customer costs per project, per experiment, per sample—and even per cell, where the company promises ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

We employed a similar approach to attempt to enrich for TaG-EM barcodes in an additional library sequenced separately from the 10x Genomics gene expression ... (23.96%), indicating that at least for ...

Single cells were captured and barcoded in 10× Chromium Controller (10× Genomics). Subsequently ... and photographs of the cell clones were taken at 10x magnification. ImageJ (15.2a) was used to ...

Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.

Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for. 10x Genomics missed analysts’ revenue expectations by 5% last quarter ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...

Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered ...